A detailed history of Engineers Gate Manager LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Engineers Gate Manager LP holds 69,725 shares of AZN stock, worth $4.81 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
69,725
Previous 18,604 274.78%
Holding current value
$4.81 Million
Previous $1.45 Million 274.62%
% of portfolio
0.11%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $3.92 Million - $4.48 Million
51,121 Added 274.78%
69,725 $5.43 Million
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $1.24 Million - $1.5 Million
18,604 New
18,604 $1.45 Million
Q3 2023

Nov 14, 2023

SELL
$64.85 - $71.7 $1.81 Million - $2 Million
-27,866 Reduced 77.08%
8,286 $561,000
Q2 2023

Aug 14, 2023

BUY
$69.91 - $75.81 $2.27 Million - $2.47 Million
32,541 Added 901.16%
36,152 $2.59 Million
Q1 2023

May 15, 2023

SELL
$63.15 - $71.6 $404,854 - $459,027
-6,411 Reduced 63.97%
3,611 $250,000
Q4 2022

Feb 14, 2023

SELL
$54.21 - $70.44 $50,252 - $65,297
-927 Reduced 8.47%
10,022 $679,000
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $580,515 - $1.49 Million
10,949 New
10,949 $600,000
Q2 2022

Aug 15, 2022

SELL
$59.26 - $71.14 $224,950 - $270,047
-3,796 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$55.72 - $67.12 $211,513 - $254,787
3,796 New
3,796 $252,000
Q1 2021

May 17, 2021

SELL
$47.16 - $54.44 $342,853 - $395,778
-7,270 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$48.52 - $58.02 $352,740 - $421,805
7,270 New
7,270 $363,000
Q3 2020

Nov 16, 2020

SELL
$53.07 - $61.1 $894,494 - $1.03 Million
-16,855 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$43.1 - $55.31 $726,450 - $932,250
16,855 New
16,855 $891,000
Q1 2020

May 15, 2020

SELL
$37.79 - $51.33 $172,700 - $234,578
-4,570 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$42.46 - $50.46 $194,042 - $230,602
4,570 New
4,570 $228,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $214B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.